Showing results (41-50 of 64) with videos related to
Sort By:
Pageof 7
Blood Advances|January 25, 2018
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignanciesMichael W Drazer, Sabah Kadri, Madina Sukhanova, et al.Cancer Research|January 22, 2009
Consistent deregulation of gene expression between human and murine MLL rearrangement leukemiasZejuan Li, Roger T Luo, Shuangli Mi, et al.Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemiaShuangli Mi, Zejuan Li, Ping Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|November 8, 2012
MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemiaXi Jiang, Hao Huang, Zejuan Li, et al.Proceedings of the National Academy of Sciences of the United States of America|October 4, 2008
Distinct microRNA expression profiles in acute myeloid leukemia with common translocationsZejuan Li, Jun Lu, Miao Sun, et al.Blood|December 25, 2012
PBX3 is an important cofactor of HOXA9 in leukemogenesisZejuan Li, Zhiyu Zhang, Yuanyuan Li, et al.Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemiaPing Chen, Colles Price, Zejuan Li, et al.Blood|September 13, 2015
Overexpression and knockout of miR-126 both promote leukemogenesisZejuan Li, Ping Chen, Rui Su, et al.Cancer Research|June 10, 2016
Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 NanoparticlesXi Jiang, Jason Bugno, Chao Hu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2018
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant MesotheliomaVasiliki Panou, Meghana Gadiraju, Arthur Wolin, et al.Pageof 7